BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Mar 08, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Tracleer bosentan: Preliminary Phase III data

Preliminary data from the double-blind, international Phase III BUILD-3 trial in 616 patients showed that 125 mg twice-daily Tracleer missed the primary endpoint of significantly reducing time to occurrence of disease worsening or death...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >